Francis Grand

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Thomas Ernst, Andrew Chase, Joannah Score et al. · Nature Genetics · 2010 · 1.1K citations

Histone Modifications, Chromatin, Chromatin Remodeling +11

Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells

Brian Cameron, Andrew B. Gerry, Joseph Dukes et al. · Science Translational Medicine · 2013 · 660 citations · Full text

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Amy V. Jones, Andrew Chase, Richard T. Silver et al. · Nature Genetics · 2009 · 380 citations · Full text

Hematological Malignancy, Major Risk Factor, Medicine +10

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

Francis Grand, Claire Hidalgo-Curtis, Thomas Ernst et al. · Blood · 2009 · 369 citations · Full text

Durable responses to imatinib in patients with PDGFRB fusion gene–positive and BCR-ABL–negative chronic myeloproliferative disorders

Marianna Dávid, Nicholas C.P. Cross, Sonja Burgstaller et al. · Blood · 2006 · 172 citations · Full text